Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release
Product Images NDC 63629-9480

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release (NDC 63629-9480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amphetamine 01)

A pharmacokinetic line graph showing mean plasma concentrations of dextroamphetamine and levoamphetamine over 24 hours. It compares two treatments: Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules 20 mg once daily, and Adderall 10 mg twice daily, indicated with separate lines for each amphetamine enantiomer.*

FDA Label Image

Label (Lbl636299480)

Label for Mixed Amphetamine Salts ER Capsules 25 mg by Bryant Ranch Prepack. The label includes dosing information, storage instructions, and a requirement for pharmacists to provide a medication guide. The package contains 100 capsules and is marked Rx only. The NDC is 63629-9480-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.